For research use only. Not for therapeutic Use.
Suxibuzone-d9(Cat No.:R045425) is a high-purity deuterated compound featuring nine deuterium atoms, essential for advanced pharmaceutical and biochemical research. This isotopically labeled version of suxibuzone is crucial for studying its metabolic pathways, pharmacokinetics, and anti-inflammatory properties. Its stable isotope labeling ensures precise and reliable analytical results, making it ideal for applications in drug metabolism studies, therapeutic efficacy research, and pharmacodynamic investigations. The enhanced stability and consistency of Suxibuzone-d9 make it suitable for various experimental setups, offering a robust and cost-effective solution for high-precision scientific investigations.
Catalog Number | R045425 |
CAS Number | NA |
Synonyms | Butanedioic Acid 1-[(4-Butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] Ester-d9, Butanedioic Acid Mono[(4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] Ester-d9, Succinic acid, Monoester with 4-Butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione-d9, 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione Hydrogen Succinate-d9, 4-Hydroxymethylbutazolidine Hemisuccinate-d9, AE 17-d9, Calibene-d9, Danilon-d9, Flogos-d9, Solurol-d9, Suxibutazone-d9 |
Molecular Formula | C₂₄H₁₇D₉N₂O₆ |
Purity | ≥95% |
Storage | Store at RT |
IUPAC Name | 4-[[4-(1,1,2,2,3,3,4,4,4-nonadeuteriobutyl)-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl]methoxy]-4-oxobutanoic acid |
InChI | InChI=1S/C24H26N2O6/c1-2-3-16-24(17-32-21(29)15-14-20(27)28)22(30)25(18-10-6-4-7-11-18)26(23(24)31)19-12-8-5-9-13-19/h4-13H,2-3,14-17H2,1H3,(H,27,28)/i1D3,2D2,3D2,16D2 |
InChIKey | ONWXNHPOAGOMTG-ZHCFYZTJSA-N |
SMILES | [2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C1(C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3)COC(=O)CCC(=O)O |